Skip to main content
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. — Investor Relations & Filings

Ticker · ENVB ISIN · US02362F3029 US Professional, scientific and technical activities
Open in API
Filings indexed 1,028 across all filing types
Latest filing 2022-08-09 Regulatory Filings
Country US United States of America
Listing US ENVB

About Enveric Biosciences, Inc.

https://www.enveric.com/

Enveric Biosciences is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of neuropsychiatric disorders. The company focuses on conditions such as anxiety, depression, and addiction. Leveraging its proprietary discovery and development platform, The Psybrary™, Enveric has created a robust intellectual property portfolio of novel molecules for specific mental health indications. Its development pipeline includes candidates such as EB-003 for difficult-to-treat mental health disorders and the EVM301 series.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2022
Regulatory Filings Classification · 95% confidence The document is a letter from Enveric Biosciences, Inc. to the SEC requesting acceleration of the effective date of a Registration Statement on Form S-3. It references a filing (Form S-3) but does not contain financial data or the report itself. The document is short (1415 characters) and is a formal request related to a regulatory filing process. This fits the category of Regulatory Filings (RNS), which includes compliance documents and correspondence with the SEC that do not constitute full reports or announcements of results.
2022-08-09 English
Regulatory Filings 2022
Regulatory Filings Classification · 90% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. There is no indication of the document being a report itself or an announcement of a report. Due to the lack of identifiable information and the fallback rule for documents that do not fit any specific category, the most appropriate classification is Regulatory Filings (RNS). The document length is 15,000 characters, which is substantial, but the content is not interpretable for more specific classification.
2022-08-09 English
Capital/Financing Update 2022
Capital/Financing Update Classification · 100% confidence The document is a Form S-3 Registration Statement filed with the SEC, dated August 5, 2022, for Enveric Biosciences, Inc. It is a registration statement under the Securities Act of 1933, used for registering securities for public offering. The text includes details about the securities being registered, selling stockholders, and the offering terms. This is a capital raising filing, not a financial report, earnings release, or management discussion. It is not an announcement of a report but the actual registration statement document. Therefore, it fits the category of Capital/Financing Update filings, which cover company fundraising and financing activities.
2022-08-05 English
Regulatory Filings 2022
Regulatory Filings
2022-08-05 English
Delisting Announcement 2022
Delisting Announcement Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC by Enveric Biosciences, Inc. The key content is about a notice of delisting or failure to satisfy a continued listing rule, specifically regarding the minimum bid price requirement by Nasdaq. The document states that the company initially failed to maintain the minimum bid price but later regained compliance. This is a regulatory announcement about the listing status of the company's stock. The document length is 3506 characters, which is relatively short and focused on a specific event. The content matches the definition of a Delisting Announcement (DLST) as it concerns the company's stock listing status and compliance with exchange rules. Therefore, the appropriate classification is DLST with high confidence.
2022-08-02 English
SCHEDULE 13G
Major Shareholding Notification
2022-08-01 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.